[1]李贺伟 吴燕茹 阮锋△.细胞黏附分子在骨肉瘤组织中的表达及沉默细胞黏附分子对骨肉瘤细胞增殖和转移的影响[J].中国中医骨伤科杂志,2022,30(07):6-10.
　LI Hewei WU Yanru RUAN Feng.The Expression of Cell Adhesion Molecule in Osteosarcoma Tissues and the Efficacy of Silencing Cell Adhesion Molecule on the Proliferation and Metastasis of Osteosarcoma Cells[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2022,30(07):6-10.
点击复制

细胞黏附分子在骨肉瘤组织中的表达及沉默细胞黏附分子对骨肉瘤细胞增殖和转移的影响()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第30卷
期数:
2022年07期
页码:
6-10
栏目:
实验研究
出版日期:
2022-07-15

文章信息/Info

Title:
The Expression of Cell Adhesion Molecule in Osteosarcoma Tissues and the Efficacy of Silencing Cell Adhesion Molecule on the Proliferation and Metastasis of Osteosarcoma Cells
文章编号:
1005-0205(2022)07-0006-05
作者:
李贺伟1 吴燕茹1 阮锋1△
1华中科技大学同济医学院附属梨园医院(武汉,430077)
Author(s):
LI Hewei1 WU Yanru1 RUAN Feng1△
1Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China.
关键词:
细胞黏附分子;  骨肉瘤;  增殖;  迁移;  侵袭;  上皮间质转化
Keywords:
cell adhesion molecule;  osteosarcoma;  proliferation;  migration;  invasion;  epithelial-mesenchymal transition
分类号:
R738.1
文献标志码:
A
摘要:
目的:探究细胞黏附分子(CD44v6)在骨肉瘤组织中的表达及沉默CD44v6对骨肉瘤细胞增殖和转移的影响。方法:实时荧光定量PCR(qRT-PCR)和蛋白免疫印迹法(Western Blot)检测骨肉瘤组织和细胞中CD44v6表达水平。将骨肉瘤细胞U2OS分为空白对照组(Control,空白培养细胞)、si-NC组(转染si-NC)、si-CD44v6组(转染si-CD44v6); qRT-PCR检测CD44v6 mRNA表达水平; Western Blot检测CD44v6、增殖细胞核抗原(PCNA)、细胞增殖核抗原67(Ki67)、钙黏附蛋白E(E-cadherin)、钙黏附蛋白N(N-cadherin)、基质金属蛋白酶9(MMP9)蛋白表达; 细胞计数试剂盒(CCK8)、克隆形成实验检测细胞增殖; Transwell检测细胞迁移、侵袭。结果:骨肉瘤组织和细胞(U2OS、MG63)中CD44v6 mRNA、蛋白表达水平明显高于癌旁组织和成骨细胞hFOB1.19。si-CD44v6组骨肉瘤细胞中CD44v6 mRNA和蛋白表达水平、PCNA、Ki67、N-cadherin、MMP9蛋白表达低于Control组、si-NC组,E-cadherin蛋白表达高于Control组、si-NC组,克隆细胞数目、迁移细胞数目、侵袭细胞数目少于Control组、si-NC组; 其中Control组、si-NC组骨肉瘤细胞中各指标差异不显著。结论:在骨肉瘤组织和细胞内CD44v6高表达,沉默CD44v6可抑制骨肉瘤细胞增殖、迁移、侵袭和上皮间质转化。
Abstract:
Objective:To explore the expression of cell adhesion molecule(CD44v6)in osteosarcoma tissues and the efficacy of silencing CD44v6 on the proliferation and metastasis of osteosarcoma cells.Methods:Real-time fluorescent quantitative PCR(qRT-PCR)and Western Blot were used to detect the expression level of CD44v6 in osteosarcoma tissues and cells.Taking the osteosarcoma cell U2OS as the research object,the cells were divided into blank control group(Control,blank cultured cells),si-NC group(transfected with si-NC)and si-CD44v6 group(transfected with si-CD44v6).The expression level of CD44v6 mRNA was detected by qRT-PCR; Western Blot was used to detect the expression of CD44v6,proliferating cell nuclear antigen(PCNA),cell proliferating nuclear antigen 67(Ki67),cadherin E(E-cadherin),cadherin N(N-cadherin)and matrix metalloproteinase 9(MMP9)Protein; cell counting kit(CCK8)and clone formation test were used to detect cell proliferation.Transwell was used to detect cell migration and invasion.Results:The expression levels of CD44v6 mRNA,protein in osteosarcoma tissues and cells(U2OS,MG63)were significantly higher than that in adjacent tissues and osteoblasts hFOB1.19.The expression levels of CD44v6 mRNA,protein,PCNA,Ki67,N-cadheri and MMP9 protein in osteosarcoma cells in the si-CD44v6 group were lower than that in the control and si-NC groups,and the E-cadherin protein expression was higher than those in the control and si-NC groups.The number of cloned cells,migrating cells and invasive cells were less than that of the control group and si-NC group.Among them,there was no significant difference in the indexes of osteosarcoma cells in the control group and si-NC group.Conclusion:The CD44v6 is highly expressed in osteosarcoma tissues and cells.The silence of CD44v6 can inhibit the proliferation,migration,invasion and epithelial-mesenchymal transition of osteosarcoma cells.

参考文献/References:

[1] CORRE I,VERRECCHIA F,CRENN V,et al.The osteosarcoma microenvironment:a complex but targetable ecosystem[J].Cells,2020,9(4):976.
[2] KAGER L,TAMAMYAN G,BIELACK S.Novel insights and therapeutic interventions for pediatric osteosarcoma[J].Future Oncol,2017,13(4):357-368.
[3] HARRISON D J,GELLER D S,GILL J D,et al.Current and future therapeutic approaches for osteosarcoma[J].Expert Rev Anticancer Ther,2018,18(1):39-50.
[4] SPIEGELBERG D,NILVEBRANT J.CD44v6-targeted imaging of head and neck squamous cell carcinoma:Antibody-based approaches[J].Contrast Media Mol Imaging,2017:2709547.
[5] NICOLAZZO C,LORENI F,CAPONNETTO S,et al.Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer[J].Oncotarget,2020,11(45):4115-4122.
[6] 龙佑梅,黄梨,王艳清,等.CD44v6通过ERK途径促进子宫内膜癌的增殖和转移[J].中国计划生育和妇产科,2020,12(7):76-79.
[7] DENG Z,NIU G,CAI L,et al.The prognostic significance of CD44v6,CDH11,and β-catenin expression in patients with osteosarcoma[J].Biomed Res Int,2013:496193.
[8] FLESNER B K,WOOD G W,GAYHEART-WALSTEN P,et al.Autologous cancer cell vaccination,adoptive T-cell transfer,and interleukin-2 administration results in long-term survival for companion dogs with osteosarcoma[J].J Vet Intern Med,2020,34(5):2056-2067.
[9] HANSEN S A,HART M L,BUSI S,et al.Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis[J].Dis Model Mech,2016,9(10):1139-1146.
[10] BIN ALAMER O,HAIDER A S,HAIDER M,et al.Primary and radiation induced skull base osteosarcoma:a systematic review of clinical features and treatment outcomes[J].J Neurooncol,2021,153(2):183-202.
[11] MA L,DONG L,CHANG P.CD44v6 engages in colorectal cancer progression[J].Cell Death Dis,2019,10(1):30.
[12] CHUNG S Y,HUANG W C,CHEN Z S,et al.Elucidation of the mechanism underlying CD44v6-induced transformation of IEC-6 normal intestinal epithelial cells[J].J Cell Physiol,2020,235(1):194-209.
[13] HU S,CAO M,HE Y,et al.CD44v6 targeted by miR-193b-5p in the coding region modulates themigration and invasion of breast cancer cells[J].J Cancer,2020,11(1):260-271.
[14] EOM B W,JOO J,PARK B,J et al.Nomogram incorporating CD44v6 and clinicopathological factors to predict lymph node metastasis for early gastric cancer[J].PLoS One,2016,11(8):e0159424.
[15] 吕林,刘海光,张筱骅.过表达CD44v6基因对人大肠癌SW480细胞侵袭迁移能力的影响[J].世界华人消化杂志,2016,24(8):1175-1183.
[16] WANG Y,YANG X,XIAN S,et al.CD44v6 may influence ovarian cancer cell invasion and migration by regulating the NF-κB pathway[J].Oncol Lett,2019,18(1):298-306.
[17] 桂容花,徐洪涛,董贺龙,等.Dishevelled-1、Cyclin D1和CD44v6在儿童骨肉瘤中的表达及临床意义[J].临床肿瘤学杂志,2016,21(9):785-788.
[18] QIU X,WANG H,WANG Z,et al.Expression of PCNA,Ki-67 and COX-2 in breast cancer based on DCE-MRI image information[J].J Infect Public Health,2020,13(12):2032-2037.
[19] CANEVER H,CAROLLO P S,FLEURISSON R,et al.Molecular tension microscopy of E-cadherin during epithelial-mesenchymal transition[J].Methods Mol Biol,2021,2179:289-299.
[20] VAN STEGEN B,DAGAR S,GOTTMANN K.Release activity-dependent control of vesicle endocytosis by the synaptic adhesion molecule N-cadherin[J].Sci Rep,2017,7:40865.
[21] HUANG H.Matrix metalloproteinase-9(MMP-9)as a cancer biomarker and MMP-9 biosensors:recent advances[J].Sensors(Basel),2018,18(10):3249.

备注/Memo

备注/Memo:
基金项目:武汉市卫生健康委员会资助项目(武卫通〔2019〕87号)
△通信作者 E-mail:a787qm@163.com
更新日期/Last Update: 1900-01-01